BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2019
View Archived Issues
LNC Therapeutics and INRA enter partnership to study anti-inflammatory properties of gut microbiome
Read More
Phase II trials of concizumab show clinical proof of concept for bleeding prevention in hemophilia
Read More
BET inhibitor JQ1(+) can be repurposed for lymphatic filariasis, new transcriptomics study suggests
Read More
Biogen discontinues development of gosuranemab for progressive supranuclear palsy
Read More
Phase II results for vasopressin V1B receptor antagonist TS-121 in MDD
Read More
Results reported from ongoing phase I study of FT-4202
Read More
ARX-788 well-tolerated in phase I study in Chinese patients with metastatic HER2+ breast cancer
Read More
Cirmtuzumab plus paclitaxel safe and well-tolerated in phase I study in breast cancer
Read More
Blood-brain barrier disruption could be Alzheimer's target
Read More
GDF1 unveiled as a therapeutic target for treating AML
Read More
Unexpected Ibrance MOA
Read More
Shanghai Zhimeng Biopharma describes potassium channel activators
Read More
Beijing Innocare Pharmaceutical Technology discovers IDO-1 inhibitors
Read More
Decoding EGFR's skin toxicity
Read More
New AXL/c-Met inhibitors disclosed by Shanghai Institute of Materia Medica
Read More
Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine patent estrogen receptor antagonists
Read More
New PI3Kgamma/PI3Kdelta inhibitors synthesized at Incyte
Read More
Chitotriosidase-1 levels rise prior to onset of ALS symptoms
Read More
FDA approves Vascepa to reduce cardiovascular risk in adults with elevated triglyceride levels
Read More
LUSTER-1 and -2 results do not support further development of fevipiprant in asthma
Read More
MHRA clears initiation of phase I trial of brilacidin delayed-release tablets
Read More
Funding supports Synedgen's optimization of therapies to restore GI integrity in IBD
Read More
Ustekinumab biosimilar DMB-3115 begins phase I trial
Read More
Basilea to advance lisavanbulin development with biomarker-driven study
Read More
Wave Life Sciences discontinues development of suvodirsen for DMD
Read More
